Skip to main content
Equibles
ACHV logo

ACHV · Achieve Life Sciences, Inc. · Webcasts, Transcripts & Audio

Track ACHV — free

Use ACHV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACHV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.98 -0.26 (-3.59%)
Russell 2000 member Rebalance outlook locked
Market Cap
$771.77M
Shares
102.90M
Volume · Oct 5 742.39K Avg daily vol (3M) 1.47M

Achieve Life Sciences, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Achieve Life Sciences, Inc. (ACHV), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q2
2026-08-11
Achieve Life Sciences, Inc. (ACHV) Q2 2026 Earnings Call
Diluted EPS
$-0.80
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2026-07-02
Achieve Life Sciences, Inc. (ACHV) July 2026 Annual General Meeting
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-12
Achieve Life Sciences, Inc. (ACHV) Q1 2026 Earnings Call Transcript
Confident tone Competitive Landscape in Smoking Cessation Unmet Need and Public Health Opportunity Commercial Launch Preparation
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-24
Achieve Life Sciences, Inc. (ACHV) Q4 2025 Earnings Call Transcript
Confident tone NDA submission and FDA progress Payer access and pricing Cytisinicline commercial launch preparation
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript
Confident tone Cytisinicline efficacy and clinical data Regulatory milestones and PDUFA Commissioner's National Priority Voucher (CNPV) for vaping
Diluted EPS
$-0.28
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript
Confident tone Commercial launch planning and Omnicom partnership Cytisinicline clinical and safety profile NDA submission and regulatory progress
Diluted EPS
$-0.37
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript
Confident tone NDA Submission Progress Cytisinicline Clinical Profile Market Opportunity and Unmet Need
Diluted EPS
$-0.37
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-11
Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript
Confident tone NDA submission for cytisinicline (smoking cessation) Market opportunity / unmet need in nicotine dependence Vaping cessation indication (ORCA-V2)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript
Confident tone Cytisinicline Product Profile and Market Opportunity NDA Submission and Regulatory Progress Vaping Phase 3 Trial (ORCA-V2)
Diluted EPS
$-0.36
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript
Confident tone Cytisinicline Regulatory Progress Vaping Cessation Indication Clinical Trial Enrollment
Diluted EPS
$-0.25
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Achieve Life Sciences, Inc. (ACHV) Q1 2024 Earnings Call Transcript
Confident tone ORCA-OL long-term safety trial initiation and enrollment NDA submission timeline and FDA agreement Vaping cessation and label expansion opportunity
Diluted EPS
$-0.26
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript
Confident tone Clinical efficacy of cytisinicline FDA agreement and NDA path forward ORCA-OL long-term safety trial
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Achieve Life Sciences, Inc. (ACHV) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.34
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Achieve Life Sciences, Inc. (ACHV) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.43
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Achieve Life Sciences, Inc. (ACHV) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-16
Achieve Life Sciences, Inc. (ACHV) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Achieve Life Sciences, Inc. (ACHV) Q3 2022 Earnings Call Transcript
Diluted EPS
$-1.35
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Achieve Life Sciences, Inc. (ACHV) Q2 2022 Earnings Call Transcript
Diluted EPS
$-1.08
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Achieve Life Sciences, Inc. (ACHV) Q1 2022 Earnings Call Transcript
Diluted EPS
$-0.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Achieve Life Sciences, Inc. (ACHV) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Achieve Life Sciences, Inc. (ACHV) Q3 2021 Earnings Call Transcript
Diluted EPS
$-0.71
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Achieve Life Sciences, Inc. (ACHV) Q2 2021 Earnings Call Transcript
Diluted EPS
$-1.53
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Achieve Life Sciences, Inc. (ACHV) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
Achieve Life Sciences, Inc. (ACHV) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
Achieve Life Sciences, Inc. (ACHV) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Achieve Life Sciences, Inc. (ACHV) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
Achieve Life Sciences, Inc. (ACHV) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-13
Achieve Life Sciences, Inc. (ACHV) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 949858 CUSIP 004468500 13F (30d) 3 filings 3 filers Visit website Investor relations